Medicare
The Centers for Medicare & Medicaid Services May 3 announced the opening of the comment period for the Inflation Reduction Act’s Medicare Drug Price Negotiation Program, which will negotiate prices with drug makers for certain high-cost, sole-source drugs and apply them beginning in 2026.…
The Medicare Hospital Insurance Trust Fund will have sufficient funds to pay full benefits until 2036, according to the latest annual report by the Medicare Board of Trustees.
The departments of Health and Human Services, Labor, and the Treasury May 1 released a new process for resubmitting disputes under the No Surprises Act independent dispute resolution process that were originally improperly batched or bundled.
The undersigned organizations write to request that accountable care organizations (ACOs) are held harmless from anomalous Medicare spending outside their control, such as the aberrant billing for catheters experienced in 2023.
Eleven organizations representing health care providers, including the AHA, April 29 urged the Centers for Medicare & Medicaid Services not to hold accountable care organizations responsible for anomalous Medicare spending beyond their control.
The voluntary Episode Quality Improvement Program for specialist physicians saved Medicare $20 million in its first year, the Maryland Health Services Cost Review Commission announced April 11.
Commenting April 12 on a proposed rule to strengthen oversight of accrediting organizations, AHA told the Centers for Medicare & Medicaid Services it supports requiring accrediting organizations to use Medicare’s Conditions of Participation and Conditions for Coverage as their minimum…
For future public health emergencies, the Centers for Medicare & Medicaid Services should improve how it sets Medicare rates for clinical diagnostic laboratory tests under the Clinical Laboratory Fee Schedule and communicates with stakeholders involved in setting the rates, the Department of…
This April through June under the Inflation Reduction Act, Medicare will reduce the coinsurance amount for 41 Part B prescription drugs from 20% to somewhere between 3.8% and 19.9%, depending on the drug, the Centers for Medicare & Medicaid Services announced March 26.
AHA recommendations to CMS regarding protecting critically ill Medicare beneficiaries through reforms to the Long-term Care Hospital PPS High-Cost Outlier Policy.